Theravance Biopharma (TBPH) Inventory (2013 - 2018)
Theravance Biopharma (TBPH) posted quarterly Inventory of $17.9 million for Q3 2018, up 17.47% year-over-year from $15.3 million in Q3 2017, and little changed quarter-over-quarter from $17.9 million in Q2 2018.
Theravance Biopharma (TBPH) Inventory (2013 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has reported Inventory for 6 consecutive years, with $17.9 million the latest figure, recorded in Q3 2018.
- In Q3 2018, Inventory rose 17.47% year-over-year to $17.9 million; the TTM figure through Sep 2018 stood at $17.9 million (up 17.47% YoY), while the FY2017 annual figure was $16.8 million, up 37.73% from the prior year.
- Inventory held at $17.9 million in Q3 2018 per TBPH's latest filing, from $17.9 million in the prior quarter.
- Across five years, Inventory topped out at $17.9 million in Q3 2018 and bottomed at $9.4 million in Q1 2016.
- Historically, Inventory has averaged $13.4 million across 5 years, with a median of $12.5 million in 2014.
- Annual changes were most pronounced in 2016 — Inventory declined 23.76% — and 2018, when it surged 47.67%.
- Theravance Biopharma's Inventory stood at $12.5 million in 2014, then dropped by 20.25% to $10.0 million in 2015, then advanced by 22.14% to $12.2 million in 2016, then soared by 37.73% to $16.8 million in 2017, then gained by 6.49% to $17.9 million in 2018.
- Business Quant data shows TBPH's Inventory at $17.9 million in Q3 2018, $17.9 million in Q2 2018, and $17.2 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 17.92 Mn |
| Jun 30, 2018 | 17.91 Mn |
| Mar 31, 2018 | 17.22 Mn |
| Dec 31, 2017 | 16.83 Mn |
| Sep 30, 2017 | 15.26 Mn |
| Jun 30, 2017 | 12.13 Mn |
| Mar 31, 2017 | 13.22 Mn |
| Dec 31, 2016 | 12.22 Mn |
| Sep 30, 2016 | 12.48 Mn |
| Jun 30, 2016 | 9.81 Mn |
| Mar 31, 2016 | 9.41 Mn |
| Dec 31, 2015 | 10.01 Mn |
| Sep 30, 2015 | 12.14 Mn |
| Jun 30, 2015 | 12.55 Mn |
| Mar 31, 2015 | 12.34 Mn |
| Dec 31, 2014 | 12.55 Mn |
| Sep 30, 2014 | 15.13 Mn |
| Jun 30, 2014 | 14.76 Mn |
| Mar 31, 2014 | 11.01 Mn |
| Dec 31, 2013 | 10.41 Mn |